RubiconMD is a company.
RubiconMD has raised $32.0M across 2 funding rounds.
Key people at RubiconMD.
RubiconMD has raised $32.0M in total across 2 funding rounds.
Key people at RubiconMD.
RubiconMD has raised $32.0M in total across 2 funding rounds.
RubiconMD's investors include Deerfield Management, Optum Ventures, Pareto Holdings, Quiet Capital, Drew Houston, John Kobs, Russell Cook.
RubiconMD is a healthcare technology company that provides an eConsult platform connecting primary care clinicians to a network of board-certified specialists across 140+ specialties for virtual consultations.[1][2][5] It serves primary care providers, health systems, value-based care organizations, and correctional healthcare facilities, solving the problem of limited access to timely specialty expertise by enabling rapid insights that reduce unnecessary referrals (by ~70%), lower costs (e.g., $1000+ per patient in corrections), and improve care efficiency without requiring patient travel.[2][4][5] As a subsidiary of Oak Street Health since its acquisition, RubiconMD has raised $35.82M, serves over 8,000 clinicians, and has delivered millions of virtual consults since 2013, demonstrating strong growth in virtual specialty care.[1][2][6]
RubiconMD was founded in 2013 in Chicago, Illinois, by Gil and Carlos, driven by their passion to improve access to medical expertise through technology.[1][2] The founders envisioned enabling primary care physicians to virtually consult specialists, enhancing patient experiences and reducing healthcare costs—a vision validated by early traction serving value-based care organizations for over 10 years.[2] Key milestones include building the first eConsult platform, expanding to the largest multi-specialty virtual network, achieving HITRUST certification, and the pivotal acquisition by Oak Street Health, which accelerated its evolution toward collaborative care models.[2][5][6]
RubiconMD rides the virtual care and telehealth wave, addressing primary care bottlenecks amid rising demand for accessible, cost-effective specialty expertise in a fragmented U.S. healthcare system strained by specialist shortages, long wait times, and inequities.[1][2][3] Its timing aligns with value-based care shifts, post-COVID telehealth adoption, and payer pressures to cut unnecessary referrals—market forces favoring scalable eConsults that deliver the "triple aim" of better outcomes, lower costs, and improved experiences.[2][5][6] By empowering community-based primary care (including underserved correctional and rural settings), it influences the ecosystem through Oak Street Health's scale, redefining specialty access and inspiring competitors like AristaMD while advancing health equity.[1][4][6]
RubiconMD is poised for expansion beyond eConsults into virtual collaborative care, leveraging Oak Street Health's resources to scale innovations for vulnerable populations and achieve mass-market impact in value-based care.[6] Trends like AI-enhanced diagnostics, broader EHR integrations, and regulatory support for telehealth will shape its trajectory, potentially amplifying savings and access amid ongoing specialist shortages. Its influence may evolve from niche leader to ecosystem standard-setter, tying back to its founding vision: making high-quality specialty care accessible to everyone, regardless of location or background.[2][6]
RubiconMD has raised $32.0M across 2 funding rounds. Most recently, it raised $18.0M Series C in March 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2020 | $18.0M Series C | Deerfield Management, Optum Ventures | |
| Apr 1, 2018 | $14.0M Series B | Pareto Holdings, Quiet Capital, Drew Houston, John Kobs, Russell Cook |
